Skip to main content
Log in

Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Background

We evaluated the clinicopathological factors associated with lymph node metastasis in patients with non-functioning pancreatic neuroendocrine neoplasms (PanNENs), focusing on the risk factors and range of lymph node metastasis for tumors ≤ 2 cm in diameter.

Methods

The subjects of this study were patients with PanNENs consecutively diagnosed at our hospital between January, 2000 and June, 2018. We analyzed 69 patients who underwent R0 resection of a non-functioning sporadic PanNEN with no distant metastasis, as well as 43 patients with tumors ≤ 20 mm in radiological diameter.

Results

Nineteen patients (27.5%), including 7 (16.3%) with a small PanNEN, had lymph node metastasis. A large radiological diameter, a high Ki67 index, and cyst formation correlated significantly with positive lymph node metastasis. In patients with tumors ≤ 20 mm in diameter, a high Ki67 index correlated significantly with lymph node metastasis. When we set the cut-off Ki67 index as 3.3%, 2 of 43 patients had lymph node metastasis. Tumors in the uncinate process readily metastasized to the region around the superior mesenteric artery.

Conclusions

These findings suggest that a high Ki67 index indicates a risk of lymph node metastasis for tumors ≤ 20 mm in diameter and that lymphadenectomy should be performed in the region spatially adjacent to the primary tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018. JNCCN. 2018;16(6):693–702. https://doi.org/10.6004/jnccn.2018.0056.

    Article  CAS  PubMed  Google Scholar 

  2. Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255–65. https://doi.org/10.1159/000464292.

    Article  CAS  PubMed  Google Scholar 

  3. Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, et al. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. J Gastroenterol. 2012;47(6):678–85. https://doi.org/10.1007/s00535-012-0540-0.

    Article  CAS  PubMed  Google Scholar 

  4. Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012;41(6):840–4. https://doi.org/10.1097/MPA.0b013e31823cdaa0.

    Article  PubMed  Google Scholar 

  5. Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259(2):197–203. https://doi.org/10.1097/SLA.0000000000000348.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wong J, Fulp WJ, Strosberg JR, Kvols LK, Centeno BA, Hodul PJ. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg. 2014;208(5):775–80. https://doi.org/10.1016/j.amjsurg.2014.04.003.

    Article  PubMed  Google Scholar 

  7. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin N Am. 2011;40(1):1–18. https://doi.org/10.1016/j.ecl.2010.12.005.

    Article  Google Scholar 

  8. Kuo EJ, Salem RR. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol. 2013;20(9):2815–21. https://doi.org/10.1245/s10434-013-3005-7.

    Article  PubMed  Google Scholar 

  9. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45(2):234–43. https://doi.org/10.1007/s00535-009-0194-8.

    Article  PubMed  Google Scholar 

  10. Han X, Xu X, Jin D, Wang D, Ji Y, Lou W. Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center. Pancreas. 2014;43(4):526–31. https://doi.org/10.1097/MPA.0000000000000065.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol. 2014;21(11):3515–21. https://doi.org/10.1245/s10434-014-3769-4.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Watzka FM, Laumen C, Fottner C, Weber MM, Schad A, Lang H, et al. Resection strategies for neuroendocrine pancreatic neoplasms. Langenbeck’s Arch Surg. 2013;398(3):431–40. https://doi.org/10.1007/s00423-012-1024-7.

    Article  CAS  Google Scholar 

  13. Yeo CJ, Wang BH, Anthone GJ, Cameron JL. Surgical experience with pancreatic islet-cell tumors. Arch Surg. 1993;128(10):1143–8.

    Article  Google Scholar 

  14. Fernandez-Cruz L, Molina V, Vallejos R, Jimenez Chavarria E, Lopez-Boado MA, Ferrer J. Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours. HPB. 2012;14(3):171–6. https://doi.org/10.1111/j.1477-2574.2011.00422.x.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sarmiento JM, Farnell MB, Que FG, Nagorney DM. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis. World J Surg. 2002;26(10):1267–71. https://doi.org/10.1007/s00268-002-6714-9.

    Article  PubMed  Google Scholar 

  16. Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011;150(1):75–82. https://doi.org/10.1016/j.surg.2011.0.

    Article  PubMed  Google Scholar 

  17. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Digest Dis Sci. 1991;36(7):933–42.

    Article  Google Scholar 

  18. Hasegawa T, Yamao K, Hijioka S, Bhatia V, Mizuno N, Hara K, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy. 2014;46(1):32–8. https://doi.org/10.1055/s-0033-1344958.

    Article  PubMed  Google Scholar 

  19. Weynand B, Borbath I, Bernard V, Sempoux C, Gigot JF, Hubert C, et al. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathology. 2014;25(6):389–95. https://doi.org/10.1111/cyt.12111.

    Article  CAS  PubMed  Google Scholar 

  20. Lee LC, Grant CS, Salomao DR, Fletcher JG, Takahashi N, Fidler JL, et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery. 2012;152(6):965–74. https://doi.org/10.1016/j.surg.2012.08.038.

    Article  PubMed  Google Scholar 

  21. Sharpe SM, In H, Winchester DJ, Talamonti MS, Baker MS. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2015;19(1):117–23 (discussion 23). https://doi.org/10.1007/s11605-014-2615-0.

    Article  Google Scholar 

  22. Gao Y, Gao H, Wang G, Yin L, Xu W, Peng Y, et al. A meta-analysis of prognostic factor of pancreatic neuroendocrine neoplasms. Sci Rep. 2018;8(1):7271. https://doi.org/10.1038/s41598-018-24072-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, et al. Comparison of recurrence between pancreatic and duodenal neuroendocrine neoplasms after curative resection: a single-institution analysis. Ann Surg Oncol. 2018;25(2):528–34. https://doi.org/10.1245/s10434-017-6260-1.

    Article  PubMed  Google Scholar 

  24. Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, et al. Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg. 2016;20(12):1966–74. https://doi.org/10.1007/s11605-016-3243-7.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by JSPS KAKENHI Grant number JP18K08677.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toshihiko Masui.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masui, T., Sato, A., Nakano, K. et al. Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms. Surg Today 49, 593–600 (2019). https://doi.org/10.1007/s00595-019-01779-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-019-01779-9

Keywords

Navigation